Exalys Therapeutics, Inc.

Pharmaceutical company · San Diego, California, United States

Exalys Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Exalys Therapeutics at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Earliest incorporation on record2018
SEC CIK1808911

What does Exalys Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $4 million sold (2020).

Frequently asked questions about Exalys Therapeutics

Where is Exalys Therapeutics headquartered?

Exalys Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Exalys Therapeutics do?

Exalys Therapeutics, Inc. is a pharmaceutical company.

When was Exalys Therapeutics founded?

The earliest incorporation on record for Exalys Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences